COMMUNIQUÉS West-GlobeNewswire
 
      -   
  Merus Announces Financial Results for the Third Quarter 2018 and Provides Business Update27/12/2018
-   
  Rubius Therapeutics to Present at the 37th Annual J.P. Morgan Healthcare Conference27/12/2018
-   
  iCAD Announces CFO Transition27/12/2018
-   
  Tauriga Sciences Inc. Selects Name & Logo Under Which it will Brand its Cannabis Infused Chewing Gum Product Line27/12/2018
-   
  Golden Leaf Holdings Ltd. Hires New CEO/President27/12/2018
-   
  Rheumatology Community Urges CMS to Proceed with Caution When Considering IPI Drug Pricing Model27/12/2018
-   
  NeuroMetrix Announces Issuance of New U.S. Patent for Quell Wearable Technology27/12/2018
-   
  Ziopharm Oncology Responds to Recent Stock Decline and Clarifies Exclusivity Rights for Clinical Assets27/12/2018
-   
  Digital Mental Health Startup headversity Launches Workplace Resilience Program27/12/2018
-   
  Ossur Hf : Transactions in relation to share buyback program27/12/2018
-   
  Bio-Path Holdings Provides Clinical Update and 2019 Business Outlook27/12/2018
-   
  VistaGen Therapeutics to Present at 11th Annual Biotech Showcase27/12/2018
-   
  PSIQ Expects Strong Revenue Growth in 2019 as President Trump Signs Farm Bill Legalizing Hemp CBD Nationwide27/12/2018
-   
  ICU Medical, Inc. to Present at the 37th J.P. Morgan Healthcare Conference27/12/2018
-   
  Retrophin Doses First Patient in Pivotal Phase 3 PROTECT Study of Sparsentan for the Treatment of IgA Nephropathy27/12/2018
-   
  MannKind Corporation to Hold Investor Conference Call27/12/2018
-   
  IBEX Grants Stock Options27/12/2018
-   
  NanoVibronix Announces Expanded Agreement with MDS Pharm Ltd. to Include Distribution of UroShield® in Israel27/12/2018
-   
  BrainStorm Issues 2018 Letter to Shareholders27/12/2018
Pages